Can-Fite BioPharma (CANF) Current Deferred Revenue (2015 - 2026)
Can-Fite BioPharma (CANF) recorded Current Deferred Revenue of $405,000 in Q2 2026, unchanged from $405,000 a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Current Deferred Revenue (2015 - 2026) Analysis & Trends
Starting with Q1 2015, Can-Fite BioPharma's Current Deferred Revenue history includes 38 quarters.
- Annual Current Deferred Revenue has a five-year compound annual growth rate of 3.9% (FY2020 to FY2025).
- Across earlier years, Current Deferred Revenue came in at $405,000 in FY2024 (-34.9%), $622,000 in FY2023 (-20.6%), $783,000 in FY2022 (-4.3%) and $818,000 in FY2021 (+144.9%).
- Quarterly Current Deferred Revenue has ranged from $405,000 in Q4 2024 to $1 million in Q3 2021 over the past five years.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 144.9% in Q4 2021, against a decline of 36.3% in Q2 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 405,000.00 |
| Dec 31, 2025 | 405,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Dec 31, 2024 | 405,000.00 |
| Jun 30, 2024 | 636,000.00 |
| Dec 31, 2023 | 622,000.00 |
| Sep 30, 2023 | 783,000.00 |
| Jun 30, 2023 | 783,000.00 |
| Mar 31, 2023 | 783,000.00 |
| Dec 31, 2022 | 783,000.00 |
| Sep 30, 2022 | 818,000.00 |
| Jun 30, 2022 | 818,000.00 |
| Mar 31, 2022 | 818,000.00 |
| Dec 31, 2021 | 818,000.00 |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 334,000.00 |
| Sep 30, 2020 | 603,000.00 |
| Jun 30, 2020 | 556,000.00 |
API Access
Can-Fite BioPharma Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();